GlassScriptPhysician profile
Drew C Dayton
NPI 1740231737
$197,909.59
in general payments reported to CMS, 2019-2025
16 companies · $34K in 2025
The $34K reported for 2025 was more than what 99% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $9,988 · 2021: $14K · 2022: $30K · 2023: $46K · 2024: $46K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $81K · Travel and Lodging: $35K · Consulting Fee: $5,450 · Food and Beverage: $5,221 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $80,952.50 |
| Travel and Lodging | $34,679.50 |
| Consulting Fee | $5,450.00 |
| Food and Beverage | $5,220.66 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $195,781.73 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $1,098.39 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $191.97 | 2022-2025 | Xiidra, Miebo, Envista Envy Iol |
| Kala Pharmaceuticals, INC. | $139.56 | 2021 | |
| Sun Pharmaceutical Industries INC. | $96.50 | 2019 | |
| Sight Sciences, INC. | $93.21 | 2021-2022 | |
| Coopervision INC. | $88.71 | 2021 | |
| Abbvie INC. | $73.78 | 2023-2025 | Lumigan |
| Oyster Point Pharma, INC. | $61.88 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $59.68 | 2024 | |
| Genentech USA, INC. | $59.07 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $58.35 | 2019-2021 | |
| Allergan, INC. | $41.12 | 2021-2022 | |
| Rxsight INC | $25.59 | 2024 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Regeneron Healthcare Solutions, INC. | $25.10 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $14.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Drew Dayton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.